ACR /ARHP congrés rhumato américain

Annual Meeting > ACR Educational Program > Wednesday
http://www.rheumatology.org/annual/index.aspLoews Philadelphia, Commonwealth Hall A-B
Current Challenges and Emerging Strategies: Optimizing the Management of Osteoarthritis Patients with Hypertension



Sponsored by Medical Education Resources, Inc.

Supported by an unrestricted educational grant from NicOx, Inc.

Physician Accreditation



This
activity has been planned and implemented in accordance with the
Essential Areas and Policies of the Accreditation Council for
Continuing Medical Education (ACCME). Medical Education Resources is
accredited by the ACCME to sponsor continuing medical education for
physicians.

Credit Designation



Medical Education Resources designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.


Learning Objectives



Upon completion of this session, participants should be able to:

• 
  Summarize recent epidemiologic and economic data to underscore the significant impact osteoarthritis has on the population
  
• 
  Describe the issues faced by clinicians who are treating patients with osteoarthritis and hypertension
  
• 
  Summarize the available pharmacologic options for the treatment of osteoarthritis and evaluate the potential benefits and risks
  
• 
  Discuss
  the role of nitric oxide on the endothelial system, focusing on the
  regulation of blood pressure and its implications in patients with
  osteoarthritis
  
• 
  Compare
  and assess the effects of Cyclooxygenase-Inhibiting Nitric Oxide
  Donating (CINOD) drugs for the treatment of patients with
  osteoarthritis and hypertension
  
• 
  Evaluate
  the current treatment recommendations for patients with osteoarthritis
  and associated cardiovascular risk factors (i.e. hypertension)
  

1:00 – 1:15 PM

Registration and Lunch


1:15 – 1:30 PM

Welcome/Overview of Symposium/Introductions
Marc C. Hochberg, MD, MPH; University of Maryland School of Medicine; Baltimore, MD


1:30 – 1:50 PM

The Burden of OA and the Associated Risks & Benefits of Current Therapies
Marc C. Hochberg, MD, MPH; University of Maryland School of Medicine; Baltimore, MD


1:50 – 2:10 PM

The Role of Nitric Oxide in Inflammation and Potential Therapeutic Applications

R. Preston Mason, PhD; Harvard Medical School; Boston, MA


2:10 – 2:30 PM

Emerging Therapies in the Management of Hypertensive Patients with Osteoarthritis
William B. White, MD; University of Connecticut School of Medicine; Farmington, CT


2:30 – 2:45 PM

Panel Discussion

Merci Vinsse,

Il est tout à fait évident que tout cela n'est qu'un feu de paille et une coquille vide...


Bonne soirée.

Merci Vincent !
et bon we à tous !